ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Simple Search Results

Didn't find what you were looking for? Try the Advanced Search »

  • « Previous Page
  • 1
  • …
  • 82
  • 83
  • 84
  • 85
  • 86
  • …
  • 96
  • Next Page »
Search Again »
  • Abstract Number: 1313 • 2016 ACR/ARHP Annual Meeting

    Rheumatologic Diseases in HIV-Infected Patients in the Post-Antiretroviral Therapy Era: The County Experience

    Muhsen Al-ani1, Yasir Abdulqader1, Robert Myers1, Napatkamon Ayutyanont‎2, Bikash Bhattarai2 and Konstantinos Parperis3, 1Internal Medicine, Maricopa Integrated Health System and University of Arizona College of Medicine, Phoenix Campus, phoenix, AZ, 2Research, Maricopa Integrated Health System, phoenix, AZ, 3Rheumatology, Maricopa Integrated Health System and University of Arizona College of Medicine, Phoenix Campus, phoenix, AZ

    Background/Purpose:  HIV infection has been associated with a plethora of rheumatologic diseases, however there are only few studies in the US analyzing the frequency of…
  • Abstract Number: 1403 • 2016 ACR/ARHP Annual Meeting

    Systematic Appraisal of the American College of Rheumatology Clinical Practice Guidelines

    Ali Duarte-Garcia1, Milena Cavalcante2, Senada Arabelovic3 and John B. Wong2, 1Medicine, Tufts Medical Center, Boston, MA, 2Tufts Medical Center, Boston, MA, 3Division of Rheumatology, Tufts Medical Center, Boston, MA

    Background/Purpose: The ACR practice guidelines establish U.S. and international treatment recommendations. We sought to characterize the quality of the guidelines using the Appraisal of Guidelines…
  • Abstract Number: 1405 • 2016 ACR/ARHP Annual Meeting

    Quality Measures in High Priority Rheumatologic Diseases: A Systematic Literature Review and Analysis

    Melissa Wells1, Stephanie Giattino1, Malithi Jayasundara1, Lisa Criscione-Schrieber1, Arif Kamal2 and Eugene William St.Clair1, 1Rheumatology, Duke University Medical Center, Durham, NC, 2Oncology, Duke University Medical Center, Durham, NC

    Background/Purpose: To identify published quality measures in rheumatoid arthritis (RA), osteoarthritis (OA), osteoporosis, spondyloarthropathy (SpA) and gout for the purpose of summarizing the existing measures…
  • Abstract Number: 1411 • 2016 ACR/ARHP Annual Meeting

    An Electronic MDHAQ (multidimensional health assessment questionnaire) Beyond an Electronic RAPID (routine assessment of patient index data): 21.3% of Rheumatoid Arthritis Patients Identified As Having Secondary Fibromyalgia Versus 3.5% By Clinicians

    Theodore Pincus and Nathaniel Cook, Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: A major impediment to use of patient questionnaires in routine clinical care has been the absence of electronic entry for patients and for doctors…
  • Abstract Number: 1699 • 2016 ACR/ARHP Annual Meeting

    RAPID3 Near Remission Shows Good Agreement with Minimal Disease Activity Criteria in Psoriatic Arthritis

    Laura C. Coates1,2, William Tillett3,4, Theodore Pincus5, Arthur Kavanaugh6 and Philip S. Helliwell7, 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 2NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom, 3Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom, 4Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, 5Rheumatology, Rush University Medical Center, Chicago, IL, 6Division of Rheumatology, Allergy, and Immunology, University of California San Diego, La Jolla, CA, 7NIHR-Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom

    Background/Purpose:  RAPID3 (routine assessment of patient index data) is a patient self-report index which is feasible in busy clinical settings to assess severity and change…
  • Abstract Number: 1957 • 2016 ACR/ARHP Annual Meeting

    No Increased Risk of Chronic Kidney Disease with Allopurinol Use

    Ana Beatriz Vargas-Santos1, Christine Peloquin2, Yuqing Zhang3 and Tuhina Neogi1, 1Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 2Clinical Epidemiology Research & Training Unit, Boston University School of Medicine, Boston, MA, 3Clinical Epidemiology and Training Unit, Boston University School of Medicine, Boston, MA

    Background/Purpose: Chronic kidney disease (CKD) is a cause and consequence of hyperuricemia. While clinicians are often cautious about using allopurinol in patients with CKD, there…
  • Abstract Number: 2159 • 2016 ACR/ARHP Annual Meeting

    Allopurinol Use Is Associated with Lower Risk of Peripheral Vascular Disease in the US Elderly

    Jasvinder A. Singh1 and John Cleveland2, 1Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 2Rheumatology, University of Alabama at Birmingham (UAB), Birmingham, AL

    Background/Purpose: Gout is associated with higher cardiovascular disease risk. Based on our previous work, there is evidence that allopurinol use reduces the risk of myocardial…
  • Abstract Number: 2190 • 2016 ACR/ARHP Annual Meeting

    Prevalence of Severe Joint Pain Among Adults with Doctor-Diagnosed Arthritis— United States, 2002–2014

    Kamil E. Barbour1, Michael Boring1, Charles Hemlick2, Louise Murphy1 and Jin Qin1, 1Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, 2Centers for Disease Control and Prevention, Atlanta, GA

    Background/Purpose:   Severe joint pain (SJP) from arthritis may reflect insufficiently managed pain, and SJP can limit an individual’s ability to perform basic functions. We…
  • Abstract Number: 2191 • 2016 ACR/ARHP Annual Meeting

    Arthritis As a Potential Barrier to Physical Activity Among Adults with Depression – United States, Behavioral Risk Factor Surveillance System, 2013

    Jennifer M. Hootman1, Louise Murphy2, Kamil E. Barbour3 and Michael Boring3, 1Division of Population Health, Centers for Disease Control and Prevention, Kennesaw, GA, 2Division of Populatio Health, Centers for Disease Control and Prevention, Atlanta, GA, 3Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA

    Background/Purpose:  Depression is one of the most common mental disorders in the United States, affecting 15.7 million adults. It frequently co-occurs with other chronic conditions…
  • Abstract Number: 2242 • 2016 ACR/ARHP Annual Meeting

    Comparison of Assessment and Management of RA and Other Rheumatic Diseases By Rheumatologists in Private Practices or an Academic Medical Center

    Anna Coleman1, Herbert Lindsley2 and Jo Wick3, 1Rheumatology, University of Kansas Medical Center, Kansas City, KS, 2Internal Medicine, University of Kansas Medical Center, Kansas City, KS, 3Biostatistics, University of Kansas Medical Center, Kansas City, KS

    Background/Purpose:  Since 80% of rheumatologists practice outside the university setting, training projects for rheumatoid arthritis (RA) may benefit from an improved understanding of RA management…
  • Abstract Number: 2243 • 2016 ACR/ARHP Annual Meeting

    The Paucity of the Evidence Base for American College of Rheumatology Practice Guidelines

    Ali Duarte-Garcia1, Richard Zamore2 and John B. Wong2, 1Medicine, Tufts Medical Center, Boston, MA, 2Tufts Medical Center, Boston, MA

    Background/Purpose: The American College of Rheumatology (ACR) practice guidelines establish U.S. and international treatment recommendations and hence performance measures and research priorities, so we sought…
  • Abstract Number: 2259 • 2016 ACR/ARHP Annual Meeting

    Suppression of Monosodium Urate Crystal-Induced Cytokine Production Via Inhibition of Histone Deacetylases 1/2

    Maartje Cleophas1, Tania Crisan2, Charles Dinarello3, M.G. Netea2 and Leo .A.B. Joosten2, 1Department of Medicine, Radboud University Medical Center, Nijmegen, Netherlands, 2Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands, 3Department of Medicine, Division of Infectious Diseases, University of Colorado, Denver, CO

    Background/Purpose: Acute gout is a highly common and painful form of inflammatory arthritis, occurring mainly in men above the age of 50. The recurring flares…
  • Abstract Number: 2260 • 2016 ACR/ARHP Annual Meeting

    Anti-Inflammatory Role of Lubricin/Proteoglycan 4 (PRG4) in Monosodium Urate (MSU)-Crystal Induced Arthritis.

    Anthony M. Reginato1, Marwa Qadri2, Changqi Sun3, Tannin Schmidt4, Nicole Yang5, Khaled Elsaid6 and Gregory Jay7, 1Rhode Island Hospital, The Warren Alpert School of Medicine at Brown University, Providence, RI, 2Department of Pharmaceutical Science, School of Pharmacy, MCHS University, Boston, MA, 3Division of Rheumatology, Rhode Island Hospital, The Warren Alpert School of Medicine at Brown University, Providence, RI, 4Kinesiology and Schulich School of Engineering, University of Calgary, Calgary, AB, Canada, 5Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Boston, MA, USA., Boston, MA, 6Biomedical and Pharmaceutical Sciences, Chapman University, Irvine, CA, 7Emergency Medicine, Brown University, Providence, RI

    Background/Purpose: Lubricin/proteoglycan-4 (PRG4) is a mucinous glycoprotein secreted by synovial fibroblast and superficial zone chondrocyte. PRG4 has a homeostatic multifaceted role in the joint including…
  • Abstract Number: 2268 • 2016 ACR/ARHP Annual Meeting

    Fructose Amplifies Inflammatory Potential in Human Monocytic Cells Via Reduction of AMP-Activated Protein Kinase Activity

    Xihua Cao1, Jeffrey N. Miner2, Robert Terkeltaub3,4 and Ru Liu-Bryan1,4, 1VA Medical Center, San Diego, CA, 2Discovery Biology, Ardea Biosciences, Inc., San Diego, CA, 3Rheumatology, VA Medical Center, San Diego, CA, 4Medicine-Rheumatology, University of California, San Diego, La Jolla, CA

    Background/Purpose: High dietary content of fructose (in table sugar, sweetened sodas, energy beverages, and fruit juices) is a substantial risk factor for both hyperuricemia and…
  • Abstract Number: 2272 • 2016 ACR/ARHP Annual Meeting

    The Influence of Genetic Variants on Renal Uric Acid Excretion in Response to Frusemide

    Nicola Dalbeth1, Jordyn de Kwant1, Gregory Gamble2, Amanda Phipps-Green3, Anne Horne2, Robert Doughty1, Lisa K. Stamp4 and Tony R. Merriman5, 1University of Auckland, Auckland, New Zealand, 2Department of Medicine, University of Auckland, Auckland, New Zealand, 3University of Otago, Dunedin, New Zealand, 4University of Otago, Christchurch, New Zealand, 5Biochemistry Dept, PO Box 56, University of Otago, Dunedin, New Zealand

    Background/Purpose: Diuretic use is strongly associated with development of hyperuricaemia and gout.  Genetic variation in the renal uric acid transporters SLC2A9 (encoding GLUT9) and SLC22A11…
  • « Previous Page
  • 1
  • …
  • 82
  • 83
  • 84
  • 85
  • 86
  • …
  • 96
  • Next Page »
Search Again »

Didn't find what you were looking for? Try the Advanced Search »

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology